Drugs & Targets FDA forms OCE Equity Program to improve clinical trial access May 24, 2024Vol.50 No.21
Drugs & Targets FDA, EMA grant Orphan Drug Designation to Carthera for carboplatin with SonoCloud technology in glioma May 17, 2024Vol.50 No.20
Drugs & Targets Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation May 17, 2024Vol.50 No.20
Drugs & Targets MCW Cancer Center leads change in Medicare policy for older patients with MDS in need of alloHCT May 10, 2024Vol.50 No.19
Drugs & Targets EMA validates application for Opdivo + Yervoy for MSI-H/dMMR mCRC May 10, 2024Vol.50 No.19
Drugs & Targets FDA issues additional draft guidance on eligibility criteria for cancer drug clinical trials May 03, 2024Vol.50 No.18
Drugs & Targets CHMP recommends approval of fruquintinib for previously-treated mCRC May 03, 2024Vol.50 No.18
